Retatrutide - Educational Material

Source / Derivation:

​​

Retatrutide is a synthetic triple-agonist peptide that targets the GLP-1, GIP, and glucagon receptors. It is designed to leverage the combined effects of incretin and glucagon signaling for enhanced metabolic regulation and energy balance.

Mechanism of Action:

​

Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors to improve insulin secretion, reduce glucagon levels, enhance satiety, and increase energy expenditure. This coordinated receptor engagement supports improved glycemic control, appetite regulation, and lipid metabolism

​

Clinical Relevance & Potential Outcomes:

​

Clinical and preclinical studies suggest that Retatrutide may promote significant improvements in body weight, glycemic control, and metabolic biomarkers, including insulin sensitivity and adiposity reduction. It represents a promising approach for multi-pathway metabolic optimization.

​

Intended Clinical Application:

​

Retatrutide may be relevant for patients requiring comprehensive metabolic support, weight management, or enhanced glycemic regulation, particularly in cases of obesity, insulin resistance, or type 2 diabetes.

Formulation & Quality Specifications:

​

• Delivered as a liquid prefilled pen

• Purity: >98% (HPLC-validated)

• Storage: 2–8 °C (refrigerated)

• Documentation: Full CoA and MSDS available

Concentration: 10 mg/ml, total 3 ml, total 30 mg

Please note that we offer educational kits designed to provide information and resources about peptides. Each purchase includes a complimentary gift.